Tilray (TLRY) Competitors $0.64 -0.03 (-4.96%) Closing price 04:00 PM EasternExtended Trading$0.64 +0.00 (+0.44%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends TLRY vs. CRON, CDXC, USNA, MNMD, SNDL, ACB, BTMD, MDWD, CGC, and FTLFShould you be buying Tilray stock or one of its competitors? The main competitors of Tilray include Cronos Group (CRON), ChromaDex (CDXC), USANA Health Sciences (USNA), Mind Medicine (MindMed) (MNMD), SNDL (SNDL), Aurora Cannabis (ACB), biote (BTMD), MediWound (MDWD), Canopy Growth (CGC), and FitLife Brands (FTLF). These companies are all part of the "medicinals & botanicals" industry. Tilray vs. Cronos Group ChromaDex USANA Health Sciences Mind Medicine (MindMed) SNDL Aurora Cannabis biote MediWound Canopy Growth FitLife Brands Tilray (NASDAQ:TLRY) and Cronos Group (NASDAQ:CRON) are both small-cap consumer staples companies, but which is the better stock? We will compare the two businesses based on the strength of their community ranking, valuation, risk, institutional ownership, analyst recommendations, earnings, profitability, media sentiment and dividends. Does the media prefer TLRY or CRON? In the previous week, Tilray had 17 more articles in the media than Cronos Group. MarketBeat recorded 19 mentions for Tilray and 2 mentions for Cronos Group. Cronos Group's average media sentiment score of 1.73 beat Tilray's score of 0.68 indicating that Cronos Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tilray 10 Very Positive mention(s) 4 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Cronos Group 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Do insiders & institutionals believe in TLRY or CRON? 9.4% of Tilray shares are held by institutional investors. Comparatively, 8.7% of Cronos Group shares are held by institutional investors. 0.9% of Tilray shares are held by insiders. Comparatively, 6.9% of Cronos Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Is TLRY or CRON more profitable? Tilray has a net margin of -30.95% compared to Cronos Group's net margin of -42.65%. Cronos Group's return on equity of -2.56% beat Tilray's return on equity.Company Net Margins Return on Equity Return on Assets Tilray-30.95% -4.40% -3.57% Cronos Group -42.65%-2.56%-2.47% Do analysts rate TLRY or CRON? Tilray presently has a consensus target price of $2.70, suggesting a potential upside of 319.91%. Cronos Group has a consensus target price of $3.00, suggesting a potential upside of 61.73%. Given Tilray's stronger consensus rating and higher probable upside, research analysts clearly believe Tilray is more favorable than Cronos Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tilray 0 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.40Cronos Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Which has better earnings and valuation, TLRY or CRON? Cronos Group has lower revenue, but higher earnings than Tilray. Tilray is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTilray$210.48M2.86-$244.98M-$0.30-2.14Cronos Group$117.62M6.03-$73.96M$0.1018.55 Which has more risk and volatility, TLRY or CRON? Tilray has a beta of 2.13, suggesting that its stock price is 113% more volatile than the S&P 500. Comparatively, Cronos Group has a beta of 0.89, suggesting that its stock price is 11% less volatile than the S&P 500. Does the MarketBeat Community believe in TLRY or CRON? Cronos Group received 16 more outperform votes than Tilray when rated by MarketBeat users. Likewise, 61.13% of users gave Cronos Group an outperform vote while only 59.26% of users gave Tilray an outperform vote. CompanyUnderperformOutperformTilrayOutperform Votes44859.26% Underperform Votes30840.74% Cronos GroupOutperform Votes46461.13% Underperform Votes29538.87% SummaryTilray and Cronos Group tied by winning 9 of the 18 factors compared between the two stocks. Remove Ads Get Tilray News Delivered to You Automatically Sign up to receive the latest news and ratings for TLRY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TLRY vs. The Competition Export to ExcelMetricTilrayMedicinals & botanicals IndustryStaples SectorNASDAQ ExchangeMarket Cap$602.91M$1.16B$16.94B$8.14BDividend YieldN/AN/A2.86%4.09%P/E Ratio-2.1447.4516.2219.29Price / Sales2.864.832.4988.94Price / CashN/A10.4016.3934.64Price / Book0.162.066.744.39Net Income-$244.98M-$53.22M$735.11M$247.05M7 Day Performance0.47%-3.00%0.62%2.07%1 Month Performance-26.40%-16.30%-4.71%-8.26%1 Year Performance-66.51%-26.40%1.70%5.87% Tilray Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TLRYTilray1.8722 of 5 stars$0.64-5.0%$2.70+320.4%-64.8%$602.16M$210.48M-2.142,650CRONCronos Group1.7123 of 5 stars$1.91+0.8%$3.00+57.5%-17.0%$728.72M$117.62M-14.65450Positive NewsCDXCChromaDex4.1506 of 5 stars$7.96+1.5%$9.03+13.6%+163.2%$618.50M$99.60M796.30120Analyst ForecastUSNAUSANA Health Sciences4.5674 of 5 stars$28.39-2.6%$36.00+26.8%-43.3%$536.71M$854.50M10.031,900MNMDMind Medicine (MindMed)1.6767 of 5 stars$6.46+1.7%$25.11+288.7%-34.9%$486.05MN/A-2.8540SNDLSNDL2.9146 of 5 stars$1.57+3.6%$3.25+107.7%+7.4%$411.24M$911.22M-5.052,516Earnings ReportAnalyst ForecastNews CoverageACBAurora Cannabis0.8409 of 5 stars$4.46+1.0%N/A+16.8%$244.39M$320.81M89.121,073News CoverageBTMDbiote3.2715 of 5 stars$4.00+6.3%$8.00+100.3%-38.9%$217.08M$197.19M15.37194Insider TradeAnalyst RevisionNews CoverageGap UpHigh Trading VolumeMDWDMediWound1.3971 of 5 stars$18.91+2.0%$31.33+65.7%+22.5%$203.96M$19.72M-6.5280Earnings ReportNews CoverageCGCCanopy Growth2.7782 of 5 stars$1.18+6.8%$2.00+70.2%-68.5%$186.37M$276.75M-0.313,150FTLFFitLife Brands4.528 of 5 stars$13.89-0.4%$20.50+47.6%+20.6%$127.93M$62.76M16.4420Analyst ForecastNews CoverageGap Up Remove Ads Related Companies and Tools Related Companies CRON Competitors CDXC Competitors USNA Competitors MNMD Competitors SNDL Competitors ACB Competitors BTMD Competitors MDWD Competitors CGC Competitors FTLF Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TLRY) was last updated on 3/19/2025 by MarketBeat.com Staff From Our PartnersElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tilray Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Tilray With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
